Evidence map›Paper›PMID 28945820›Full record

ArticlePLoS pathogens2017

Anthrax edema toxin disrupts distinct steps in Rab11-dependent junctional transport.

Annabel Guichard, Prashant Jain, Mahtab Moayeri, Ruth Schwartz, Stephen Chin, Lin Zhu, Beatriz Cruz-Moreno, Janet Z Liu, Bernice Aguilar, Andrew Hollands and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. International journal of molecular sciences · 2021
    Review
  8. Article
  9. Article
  10. Autocrine-paracrine prostaglandin ENature immunology · 2018
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Annabel GuichardSection of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA, United States of America.
Prashant JainSection of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA, United States of America.
Mahtab MoayeriLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, United States of America.
Ruth SchwartzSection of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA, United States of America.ORCID http://orcid.org/0000-0001-8448-8522
Stephen ChinSection of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA, United States of America.ORCID http://orcid.org/0000-0002-8224-4273
Lin ZhuSection of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA, United States of America.ORCID http://orcid.org/0000-0002-4238-3594
Beatriz Cruz-MorenoSection of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA, United States of America.
Janet Z LiuDepartment of Pediatrics, University of California, San Diego, La Jolla, CA, United States of America.ORCID http://orcid.org/0000-0002-9306-127X
Bernice AguilarDepartment of Pediatrics, University of California, San Diego, La Jolla, CA, United States of America.ORCID http://orcid.org/0000-0002-0643-7460
Andrew HollandsDepartment of Pediatrics, University of California, San Diego, La Jolla, CA, United States of America.ORCID http://orcid.org/0000-0002-6897-2354
Stephen H LepplaLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, United States of America.
Victor NizetDepartment of Pediatrics, University of California, San Diego, La Jolla, CA, United States of America.
Ethan BierSection of Cell and Developmental Biology, University of California, San Diego, La Jolla, CA, United States of America.ORCID http://orcid.org/0000-0002-2892-3005
University of California San Diego · USNational Institute of Allergy and Infectious Diseases · USCedars-Sinai Medical Center · US

Funding

Pathophysiological Actions of the Anthrax ToxinsZIAAI001032 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LEPPLA, STEPHEN · 2009 to 2025
$10.9M
U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
Analyzing a novel mechanism of action of bacterial cAMP producing toxinsR01AI110713 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BIER, ETHAN, NIZET, VICTOR · 2014 to 2018
$2.7M
The mutagenic chain reaction: a method for autocatalyic gene disseminationR01GM117321 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BIER, ETHAN · 2016 to 2024
$2.5M
Development of next-generation gene drive technologies for Anopheles population engineeringR01AI162911 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BIER, ETHAN · 2021 to 2025
$2.3M
Analysis of homolog-based CRISPR editing in somatic cellsR01GM144608 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BIER, ETHAN · 2022 to 2025
$1.3M
Analyzing Anthrax Toxins in DrosophiliaR56AI070654 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BIER, ETHAN · 2013 to 2013
$364k
Intramural NIH HHS ZIA AI001032NIAID NIH HHS R01 AI110713NIAID NIH HHS R01 AI162911NIAID NIH HHS R56 AI070654NIGMS NIH HHS R01 GM117321NIGMS NIH HHS R01 GM144608NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

Various bacterial toxins circumvent host defenses through overproduction of cAMP. In a previous study, we showed that edema factor (EF), an adenylate cyclase from Bacillus anthracis, disrupts endocytic recycling mediated by the small GTPase Rab11. As a result, cargo proteins such as cadherins fail to reach inter-cellular junctions. In the present study, we provide further mechanistic dissection of Rab11 inhibition by EF using a combination of Drosophila and mammalian systems. EF blocks Rab11 trafficking after the GTP-loading step, preventing a constitutively active form of Rab11 from delivering cargo vesicles to the plasma membrane. Both of the primary cAMP effector pathways -PKA and Epac/Rap1- contribute to inhibition of Rab11-mediated trafficking, but act at distinct steps of the delivery process. PKA acts early, preventing Rab11 from associating with its effectors Rip11 and Sec15. In contrast, Epac functions subsequently via the small GTPase Rap1 to block fusion of recycling endosomes with the plasma membrane, and appears to be the primary effector of EF toxicity in this process. Similarly, experiments conducted in mammalian systems reveal that Epac, but not PKA, mediates the activity of EF both in cell culture and in vivo. The small GTPase Arf6, which initiates endocytic retrieval of cell adhesion components, also contributes to junctional homeostasis by counteracting Rab11-dependent delivery of cargo proteins at sites of cell-cell contact. These studies have potentially significant practical implications, since chemical inhibition of either Arf6 or Epac blocks the effect of EF in cell culture and in vivo, opening new potential therapeutic avenues for treating symptoms caused by cAMP-inducing toxins or related barrier-disrupting pathologies.

Indexed as

Adenylyl CyclasesADP-Ribosylation Factor 6ADP-Ribosylation FactorsAnimalsAntigens, BacterialBacterial ToxinsCadherinsCell LineEdemaEndosomesIntercellular JunctionsProtein Transportrab GTP-Binding ProteinsAdenylyl CyclasesADP-Ribosylation Factor 6ADP-Ribosylation Factorsanthrax toxinAntigens, BacterialBacterial ToxinsCadherinsrab GTP-Binding Proteins

Identifiers

PMID28945820
PMCPMC5612732
OpenAlexW2758643748

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.